Kevin Hern: “If I may, just to fast forward that, with the change in 2018 November election, there was a decline in small business…”

When you’re spending at twice the rate of what your revenue growth is, that’s a problem.

It is sad that what we are dealing with is stifled innovation and a decrease in patient access due to the Inflation Reduction Act.

It is critical that we keep innovation here in the U.S., but it is also critical that we make sure healthcare is affordable.

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.